Literature DB >> 31938211

miR-944 inhibits cell migration and invasion by targeting MACC1 in nasopharyngeal carcinoma.

Juanjuan Ji1, Yi Peng2, Tao Niu2, Yunhong Lin2, Yan Lin3, Xudong Li2, Xiaoguang Wu3, Zhiyong Huang2, Ling Zhong3, Shinan Zhang2.   

Abstract

Nasopharyngeal carcinoma (NPC) is a common disease in Southern China with high prevalence. miR-944 has been reported to play a vital role in progression of a variety of cancers. The present study aimed to investigate the potential role of miR-944 in NPC cell migration and invasion through elucidating the interaction with its target genes, MACC1. Expression of miR-944 in NPC tissues and cell lines was examined with quantitative RT-PCR. Overexpressed miR-944 and suppressed miR-944 were established with miR-944 mimics and miR-944 inhibitor, respectively. The effect of miR-944 on cell migration and invasion was determined using Transwell cell migration and Matrigel invasion assay. Luciferase assay was used to determine the target of miR-944. Knocked down of MACC1 was done by MACC1 siRNA. Expression of MET related-markers was examined using Western blot analysis. The expression level of miR-944 was downregulated in NPC tissues and cell lines. Overexpression of miR-944 significantly inhibited the cell migration and invasion in NPC 6-10B cells. In contrast, suppression of miR-944 promoted cell migration and invasion in NPC C-6661 cells. MACC1 is a direct target of miR-944. MACC1 expression was repressed in miR-944 mimic transfected cells while it was enhanced in miR-944 inhibitor transfected cells. MACC1 knock down inhibited cell migration and invasion. Either miR-944 restoration or MACC1 knockdown caused enhanced E-cadherin, reduced N-cadherin, and vimentin expression. In conclusion, miR-944 could inhibit MET and metastasis of NPC by targeting MACC1. This study suggests that miR-944 has anti-tumor and anti- metastatic properties and could thus be a novel therapeutic agent for NPC treatment. IJCEP
Copyright © 2018.

Entities:  

Keywords:  MACC1; Nasopharyngeal carcinoma; cell migration; invasion; miR-944

Year:  2018        PMID: 31938211      PMCID: PMC6958143     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  28 in total

1.  Prognostic factors in patients with nasopharyngeal carcinoma treated in Hospital Kuala Lumpur.

Authors:  Esam El-Sherbieny; Hesham Rashwan; Syarif Husin Lubis; Voon Jan Choi
Journal:  Asian Pac J Cancer Prev       Date:  2011

Review 2.  Prognostic and clinicopathological significance of MACC1 expression in hepatocellular carcinoma patients: a meta-analysis.

Authors:  Da-Wei Sun; Ying-Yi Zhang; Yue Qi; Gui-Qi Liu; Yu-Guo Chen; Jian Ma; Guo-Yue Lv
Journal:  Int J Clin Exp Med       Date:  2015-04-15

3.  miR-944 acts as a prognostic marker and promotes the tumor progression in endometrial cancer.

Authors:  Zhonghui He; Hong Xu; Yugang Meng; Yan Kuang
Journal:  Biomed Pharmacother       Date:  2017-02-06       Impact factor: 6.529

4.  MiR-1 downregulation cooperates with MACC1 in promoting MET overexpression in human colon cancer.

Authors:  Cristina Migliore; Valentina Martin; Vera P Leoni; Angelo Restivo; Luigi Atzori; Annalisa Petrelli; Claudio Isella; Luigi Zorcolo; Ivana Sarotto; Giuseppe Casula; Paolo M Comoglio; Amedeo Columbano; Silvia Giordano
Journal:  Clin Cancer Res       Date:  2011-12-16       Impact factor: 12.531

5.  MACC1, a newly identified key regulator of HGF-MET signaling, predicts colon cancer metastasis.

Authors:  Ulrike Stein; Wolfgang Walther; Franziska Arlt; Holger Schwabe; Janice Smith; Iduna Fichtner; Walter Birchmeier; Peter M Schlag
Journal:  Nat Med       Date:  2008-12-21       Impact factor: 53.440

6.  Overexpression of MACC1 protein and its clinical implications in patients with glioma.

Authors:  Tao Yang; Bin Kong; Yong-Qin Kuang; Lin Cheng; Jian-Wen Gu; Jun-Hai Zhang; Hai-Feng Shu; Si-Xun Yu; Wei-Qi He; Xue-Min Xing; Hai-Dong Huang
Journal:  Tumour Biol       Date:  2013-08-28

Review 7.  MACC1 - a novel target for solid cancers.

Authors:  Ulrike Stein
Journal:  Expert Opin Ther Targets       Date:  2013-07-02       Impact factor: 6.902

Review 8.  Nasopharynx cancer: therapeutic value of chemoradiotherapy.

Authors:  Brian O'Sullivan
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007       Impact factor: 7.038

9.  MACC1 down-regulation inhibits proliferation and tumourigenicity of nasopharyngeal carcinoma cells through Akt/β-catenin signaling pathway.

Authors:  Fengjiao Meng; Hui Li; Huijuan Shi; Qingxu Yang; Fenfen Zhang; Yang Yang; Lili Kang; Tiantian Zhen; Sujuan Dai; Yu Dong; Anjia Han
Journal:  PLoS One       Date:  2013-04-03       Impact factor: 3.240

10.  MACC1 induces metastasis in ovarian carcinoma by upregulating hepatocyte growth factor receptor c-MET.

Authors:  Xiu-Jie Sheng; Zhen Li; Man Sun; Zhi-Hui Wang; Dong-Mei Zhou; Jian-Qi Li; Qin Zhao; Xiao-Fang Sun; Qi-Cai Liu
Journal:  Oncol Lett       Date:  2014-05-27       Impact factor: 2.967

View more
  2 in total

1.  Long Noncoding RNA FGD5-AS1 Knockdown Decrease Viability, Migration, and Invasion of Non-Small Cell Lung Cancer (NSCLC) Cells by Regulating the MicroRNA-944/MACC1 Axis.

Authors:  Jian Lv; Qinyong Li; Ruiqiang Ma; Zhen Wang; Yingyu Yu; Huan Liu; Yuanxiu Miao; Shujuan Jiang
Journal:  Technol Cancer Res Treat       Date:  2021 Jan-Dec

Review 2.  Novel Insights into miR-944 in Cancer.

Authors:  Jinze Shen; Qurui Wang; Chenhao Liang; Xinming Su; Yufei Ke; Yunan Mao; Jie Fang; Shiwei Duan
Journal:  Cancers (Basel)       Date:  2022-08-31       Impact factor: 6.575

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.